EUVIMEDEUVIMED entdecken
Crossref

Nanomicelle-Based Sublingual Film for Repaglinide Delivery: Formulation, Optimization, and In Vitro Evaluation

Zainab Ahmed Sadeq, Lubna Abdalkarim Sabri

Pharmaceutical Sciences · 31.10.2026 · 32 (4) · 602-610

DOI: 10.34172/ps.43837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Sciences, online erschienen am 01.08.2026. Verfasst von Zainab Ahmed Sadeq und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Repaglinide is an antidiabetic agent classified as a meglitinide. It exhibits poor solubility and high permeability, categorizing it as a Class II drug according to the Biopharmaceutics Classification System (BCS). Its poor water solubility contributes to its limited oral bioavailability.

Methods

In this study, the dissolution rate of repaglinide was improved through the nanomicelles (NMs) formation and converting these NMs into a sublingual film (SLF) for its rapid disintegration, and ease of administration. The thin film hydration method was employed for the preparation of repaglinide micellar dispersions using Soluplus® and poloxamer 338. Furthermore, repaglinide NM-loaded SLF were developed via the solvent casting technique. The Box-Behnken design was used to study the effect of different formulation parameters on film disintegration time and percentage elongation (E%).

Results

The optimized formulation exhibited a desirability value of 0.73, with a disintegration time of 23 seconds and a percentage elongation of 17%. Drug release was significantly enhanced, achieving 100% release within 10 minutes, whereas the conventional film demonstrated only 31% release over the same period.

Conclusion

The developed NM-loaded SLF represents a promising approach for enhancing the release of repaglinide, potentially improving its oral delivery and therapeutic performance.

Zitieren

APA

Sadeq, Z. A., & Sabri, L. A. (2026). Nanomicelle-Based Sublingual Film for Repaglinide Delivery: Formulation, Optimization, and In Vitro Evaluation. Pharmaceutical Sciences, 32(4), 602-610. https://doi.org/10.34172/ps.43837

Vancouver

Sadeq ZA, Sabri LA. Nanomicelle-Based Sublingual Film for Repaglinide Delivery: Formulation, Optimization, and In Vitro Evaluation. Pharmaceutical Sciences. 2026;32(4):602-610. doi:10.34172/ps.43837

BibTeX
@article{Sadeq2026,
  author = {Sadeq, Zainab Ahmed and Sabri, Lubna Abdalkarim},
  title = {Nanomicelle-Based Sublingual Film for Repaglinide Delivery: Formulation, Optimization, and In Vitro Evaluation},
  journal = {Pharmaceutical Sciences},
  year = {2026},
  volume = {32},
  number = {4},
  pages = {602--610},
  doi = {10.34172/ps.43837}
}
Kostenlos starten →